Overview
Share price change
24h
Current
Min
1.06
Max
1.47
Income | 14M -6M |
|---|---|
Employees | 112 |
EBITDA | 3.3M -18M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +175.86% upside |
Next Earnings | 9 lis 2026 |
|---|
Market Cap | 56M 160M |
|---|---|
Previous open | 17.18 |
Previous close | 1.21 |
Inovio Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
5 lis 2026, 23:56 UTC
Rigel Pharmaceuticals reports Q3 2026 net income of $13.2 million, missing expectations, and revises full-year revenue guidance down to $290-$295 million.
Read
5 lis 2026, 23:51 UTC
The Chefs' Warehouse, Inc. shares are moving lower after reporting third-quarter sales of $1.14 billion, amid a broader market decline.
Read
5 lis 2026, 23:51 UTC
Century Aluminum reports Q3 net sales of $961.2 million, exceeding estimates, but adjusted EPS of $2.58 missed expectations of $2.75. Q4 EBITDA guidance set at $275M-$300M.
Read
5 lis 2026, 23:51 UTC
Alector, Inc. reported Q3 earnings of $1.11 per share, exceeding estimates, with revenue of $162.87 million driven by collaboration with Glaxo Wellcome UK.
Read
5 lis 2026, 23:41 UTC
JP Morgan maintains Underweight rating on Snap Inc and lowers price target to $5, contributing to the stock's decline in after-market hours.
Read
5 lis 2026, 23:41 UTC
iRhythm Holdings reports Q3 adjusted EPS of $0.82, raises full-year 2026 sales guidance to $890M-$895M, but revenue misses estimates at $221.59M.
Read
5 lis 2026, 23:41 UTC
Blue Owl Capital Inc. is moving lower in after-market hours amid a broader market decline, influenced by negative sentiment and recent economic data.
Read
5 lis 2026, 23:41 UTC
BTIG maintains its Buy rating on LifeStance Health and raises its price target to $20, while Canaccord increases its target to $16.
Read
5 lis 2026, 23:41 UTC
A securities class action lawsuit has been filed against Duolingo, Inc. by Levi & Korsinsky, LLP, alleging concealed issues with user growth and product quality.
Read
5 lis 2026, 23:36 UTC
Arch Capital Group Ltd. increases its share repurchase program by $3 billion, raising total authorization to $3.6 billion, as detailed in an SEC filing.
Read
5 lis 2026, 23:36 UTC
ARK Genomic Revolution ETF declined in after-market trading as several holdings reported larger-than-expected net losses, with Pacific Biosciences also falling modestly.
Read
5 lis 2026, 23:31 UTC
e.l.f. Beauty, Inc. shares declined during after-market hours, moving lower alongside the broader market amid ongoing stock market volatility and falling Treasury yields.
Read
5 lis 2026, 23:31 UTC
Sarepta Therapeutics reported Q3 adjusted EPS of $0.13 and revenue of $381.4 million, but projected Q4 revenue at Q3 levels, raising investor concerns.
Read
5 lis 2026, 23:31 UTC
Yelp lowers fiscal year 2026 sales guidance to $1.455B-$1.460B and projects Q4 revenue of $347M-$352M, below consensus estimates.
Read
5 lis 2026, 23:31 UTC
EverCommerce Inc reported Q3 earnings of $0.03, missing estimates, and lowered 2026 revenue guidance to $600 million from $612 million.
Read
5 lis 2026, 23:31 UTC
Array Technologies Inc shares declined during after-market hours, following the broader market trend, despite earlier rebounding from a session low.
Read
5 lis 2026, 23:26 UTC
Crocs, Inc. shares traded modestly lower in after-market hours despite raising its full-year 2026 guidance and reporting revenue growth for the third quarter.
Read
5 lis 2026, 23:26 UTC
Citigroup maintains Neutral rating on Insulet Corporation and raises price target to $170, with shares trading lower in after-market hours.
Read
5 lis 2026, 23:22 UTC
Credo Technology Group Holding Ltd shares are lower in after-market trading, influenced by disappointing earnings and guidance from major semiconductor companies.
Read
5 lis 2026, 23:22 UTC
Vertex Pharmaceuticals is declining in after-market trading, influenced by broader market concerns and a drop in the iShares Biotechnology ETF (IBB).
Read
5 lis 2026, 23:22 UTC
NVIDIA Corporation's stock fell sharply, losing approximately $451 billion in market value, marking its worst day since January 2025 amid a broader tech sell-off.
Read
5 lis 2026, 23:22 UTC
TTM Technologies Inc is under investigation by Kirby McInerney LLP for potential federal securities law violations following disappointing fourth-quarter revenue guidance.
Read
5 lis 2026, 23:22 UTC
Micron Technology board member Linnie M. Haynesworth will retire at the annual shareholders meeting on January 14, 2027, reducing the board to eight directors.
Read
5 lis 2026, 23:21 UTC
Qualcomm's stock declined sharply after the company reported weak earnings and falling smartphone chip sales, contributing to a broader semiconductor selloff.
Read
5 lis 2026, 23:21 UTC
Encore Capital Group, Inc. shares are higher in after-market trading following a strong Q3 earnings report, with GAAP EPS rising 76% to $5.57.
Read
5 lis 2026, 23:21 UTC
Northern Oil and Gas reported Q3 adjusted EPS of $1.32, exceeding estimates, and raised its 2026 production outlook to 147k-150k boe/d.
Read
5 lis 2026, 23:16 UTC
MasterBrand, Inc. reported a third-quarter net loss of $9.2 million and projected fourth-quarter adjusted EPS between -$0.12 and -$0.08, below consensus.
Read
5 lis 2026, 23:16 UTC
Citigroup maintains Neutral rating on Rapid7, Inc. and raises price target to $16 in a report published after market hours.
Read
5 lis 2026, 23:12 UTC
Bearish options activity surges with 126k contracts traded.
Read
5 lis 2026, 23:11 UTC
Fluence Energy, Inc. faces a class action lawsuit from Levi & Korsinsky, LLP, over alleged false statements regarding its fiscal 2026 revenue guidance.
Read
Peer Comparison
Price change
Inovio Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 4 USD 175.86%
High 5 USD
Low 3 USD
Based on 3 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.
Rating Consensus
By TipRanks
Strong Buy
3 ratings
3
Buy
0
Hold
0
Sell
Based on 3 analysts giving stock ratings to Inovio Pharmaceuticals Inc - Dist in the past 3 months.
Financials
Selling and administration expenses
Pre-tax profit
Sales
Interest expense on debt
EBITDA
Operating profit
$